Global Immunoglobulins Market Growth:
The global immunoglobulins market shall expand strongly at a CAGR of 7.0% during the forecast period (2020-2026), largely attributed to the upsurge in prevalence of autoimmune diseases. According to the Immune Deficiency Foundation (IDF), approximately 83 per 100,000 people in North America suffered from primary immunodeficiency in 2017, covering 350 genetic diseases. As the global geriatric population increases, so does the demand for better immunological treatments.
Moreover, a steady increase in the usage of immunoglobulins for the treatment of off-label indications is also rising. Common off-label indications treated with intravenous and subcutaneous immunoglobulins include Guillain Barre Syndrome, multifocal motor neuropathy, dermatomyositis and stiff person syndrome. The ongoing novel coronavirus pandemic shall also leverage the global immunoglobulins market, as healthcare providers are exhaustively researching on the application of immunoglobulins in the treatment of COVID-19.
Global Immunoglobulins Market Study: By Application:
The neurology segment held the maximum market share throughout the historical period, comprising almost 2/5th of the global immunoglobulins market. This trend is expected to continue across the forecast period. The immunology segment accounted for the 2nd largest share in the global immunoglobulins market and is poised to capture over 35% market share throughout the forecast period.
Intravenous, subcutaneous and intramuscular immunoglobulins are effective for the treatment of rare disorders in the neurology and immunology disease segments, hence the increasing market share. The number of patients suffering from disorders such as multifocal motor neuropathy, primary humoral immunodeficiency and Guillain Barre Syndrome are also increasing.
To get the latest COVID-19 impact insights on the immunoglobulins market, request for a report sample here
Global Immunoglobulins Market Study: By Route of Administration:
Intravenous immunoglobulin administration, capturing more than three-quarters of the market, will expand at a CAGR of 7.0% during the forecast period. At the same time, the subcutaneous (SCIG) administration segment is anticipated to expand rapidly, at a CAGR of 8.3% in the total immunoglobulins market.
Approval of intravenous immunoglobulin (IVIG) products for chronic and rare diseases, are projected to uplift the market. Moreover, growing acceptance amongst patients due to advantages such as lower rate of non-serious systemic adverse reactions shall drive the growth of the subcutaneous administration segment.
Global Immunoglobulins Market Size: Regional Insights:
North America shall remain the kingpin of the global immunoglobulins market across the forecast period, expanding healthily at a CAGR of 7.1% during the forecast period and capturing a market share of more than two-fifth. Trailing behind is the Asia-Pacific region, expanding at a CAGR of 8.5% and capturing more than a quarter of the global immunoglobulins market.
Growth in North America is attributed to the high prevalence of neurological, immunological and other disorders, high adoption of IVIG products and significant reimbursement coverage along with presence of major market players. Expanding healthcare market, untapped potential, and acceptance of immunoglobulins products in developing countries and increasing geriatric population are the key drivers augmenting growth of the Asia-Pacific market.
To get exclusive regional insights on the immunoglobulins market, ask an analyst here
Global Immunoglobulins Market Key Players
The global immunoglobulins market is highly consolidated, with the top three players constituting more than three-fifths of the overall market share. These three key players are Grifols S.A, Shire and CSL Behring. Other prominent players include Octapharma, Kedrion Biopharma Inc., China Biologic Products Holdings, Inc., Biotest AG, Sanquin and LFB SA. Most of these companies concentrate on molecular immunoglobulins indications and subsequent development of pipeline products.
Grifols S.A, for instance, manufactures Gamunex C and Flebogamma Intravenous immunoglobulin products. Gamunex C is a sterilized solution made from human plasma which contains antibodies to treat primary immunodeficiency. This includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency and Wiskott - Aldrich syndrome. On a similar plane, CSL Behring is engaged in producing subcutaneous immunoglobulin products such as Privigen, Evogam and Beriglobin P. Berigloin P is presented in the form of an injection containing excipients of glycine, sodium chloride, hydrochloric acid or sodium hydroxide and water.
COVID-19’s Impact on the Global Immunoglobulins Market:
As the coronavirus pandemic suffocates the entire world, leading healthcare practitioners are researching extensively on finding potential cures for this deadly virus. The pandemic has provided a platform for the immunoglobulins market to become elevated on a higher growth pedestal. For instance, in India, Bharat Biotech is leading a project to develop monoclonal antibodies as a possible therapy for COVID-19. The project is sanctioned by the Council of Scientific and Industrial Research (CSIR) under its New Millennium Indian Technology Leadership initiative.
On a similar plane, Grifols continues to advance its research and supports integrated efforts for developing clinical trials on convalescent plasma transfusions as well as on the application of anti-coronavirus hyperimmune globulin. Another market player, CSL Behring Ltd., is part of a larger alliance of the world’s leading plasma companies titled the CoVIg-19 Plasma Alliance. The purpose of this project is to make extensive usage of immunoglobulins for the development of an investigational medicine to test whether such a drug could help develop immunity to the virus. All these efforts are directly and indirectly contributing to the growth of the immunoglobulins market.
“Rising prevalence of immunological disorders are anticipated to provide a launching pad for the growth of the immunoglobulins market. North America and the Asia-Pacific shall emerge as booming hubs, attributed to a rapidly advancing healthcare infrastructure.”
Global Immunoglobulins Market: Report Scope:
The recent report on the global immunoglobulins market published by Fact.MR incorporates a 6-year forecast period between 2020 and 2026. The report elaborates on vital dynamics such as the drivers, restraints and opportunities associated with the immunoglobulins market. Market analysis has been presented on the basis of the following segments: application, route of administration and end-user. Each segment has been analyzed on the basis of its revenue, market share and year-on-year growth projections.
A section on the market’s regional landscape incorporating the abovementioned segments has also been included. The regional landscape has been mapped based on the following geographies: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. In the final part of the report, a competition landscape detailing key market players’ revenue and market shares, product portfolios and key collaborations have been embedded. In addition, each market player also includes a SWOT analysis in order to provide a realistic picture of future growth.
Global Immunoglobulins Market- Scope of the Report
The recent study by Fact.MR on global Immunoglobulins market offers a 6-year forecast between 2020 and 2026. The study analyzes crucial trends that are currently determining the growth of global immunoglobulins market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the manufacturing of immunoglobulins. The study also provides dynamics that are responsible for influencing the future status of the global Immunoglobulins market over the forecast period.
A detailed assessment of the global immunoglobulins market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global Immunoglobulins market along with their product portfolio enhances the reliability of this comprehensive research study.
Global Immunoglobulins Market: Report Summary
The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in global immunoglobulins market across the globe.
A comprehensive estimate of the global immunoglobulins market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of the global immunoglobulins market during the forecast period. Price point comparison by region with global average price is also considered in the study.
Global Immunoglobulins Market Segmentation
Fact.MR has studied the global immunoglobulins market with detailed segmentation on the basis of Application, Route of Administration, End-user and key regions.
Route of Administration
Middle East & Africa (MEA)
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
Global Immunoglobulins Market: Analysis on Market Size Evaluation
The global immunoglobulins market has been analyzed for each market segment, in terms of value (US$ Mn).
Market estimates at global and regional levels for immunoglobulins is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent guidewire market segments, along with market attractiveness evaluation has been incorporated in the report.
Global Immunoglobulins Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the global immunoglobulins report, which have helped to deliver projection on the regional markets. These chapters include the regional macros (economic, and business environment outlook), which are expected to have a momentous influence on the growth of the global Immunoglobulins market during the forecast period.
Country-specific valuation on demand for immunoglobulins has been offered for each regional market, along with the market scope, estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Global Immunoglobulins Market: In-Depth Analysis on Competitive Landscape
The report sheds light on the leading manufacturers of global immunoglobulins along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of immunoglobulins, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global immunoglobulins market. Prominent manufacturers with established market presence in the global immunoglobulins market are Shire, CSL Behring, Kedrion Biopharma Inc., Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc., Biotest AG, Sanquin and LFB SA.
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Immunoglobulins Market
4. Market Overview
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.3. Market Dynamics
4.4. Global Immunoglobulins Market Analysis and Forecast, 2020–2026
4.4.1. Global Immunoglobulins Market Value (US$ Mn) Projections
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Regulatory Scenario by Region/globally
5.3. Pipeline Analysis
6. Global Immunoglobulins Market Analysis and Forecast, by Applications
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Immunoglobulins Market Value Forecast, by Applications, 2020–2026
6.4. Global Immunoglobulins Market Attractiveness by Applications
7. Global Immunoglobulins Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Immunoglobulins Market Value Forecast, by Route of Administration, 2020–2026
7.4. Global Immunoglobulins Market Attractiveness by Route of Administration
8. Global Immunoglobulins Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Immunoglobulins Market Value Forecast, by End-user, 2020–2026
8.4. Global Immunoglobulins Market Attractiveness by End-user
9. Global Immunoglobulins Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Immunoglobulins Market Value Forecast, by Region
9.2.1. North America
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Immunoglobulins Market Attractiveness, by Country/Region
10. North America Immunoglobulins Market Analysis and Forecast
10.1.1. Key Findings
10.2. North America Immunoglobulins Market Value Forecast, by Applications, 2020–2026
10.3. North America Immunoglobulins Market Value Forecast, by Route of Administration, 2020–2026
10.4. North America Immunoglobulins Market Value Forecast, by End-user, 2020–2026
10.5. North America Immunoglobulins Market Value Forecast, by Country, 2020–2026
10.6. North America Immunoglobulins Market Attractiveness Analysis
10.6.1. By Applications
10.6.2. By Route of Administration
10.6.3. By End-user
10.6.4. By Country
11. Europe Immunoglobulins Market Analysis and Forecast
11.1.1. Key Findings
11.2. Europe Immunoglobulins Market Value Forecast by Applications, 2020–2026
11.3. Europe Immunoglobulins Market Value Forecast, by Route of Administration, 2020–2026
11.4. Europe Immunoglobulins Market Value Forecast, by End-user, 2020–2026
11.5. Europe Immunoglobulins Market Value Forecast, by Country/Sub-region, 2020–2026
11.5.6. Rest of Europe
11.6. Europe Immunoglobulins Market Attractiveness Analysis
11.6.1. By Applications
11.6.2. By Route of Administration
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Immunoglobulins Market Analysis and Forecast
12.1.1. Key Findings
12.2. Asia Pacific Immunoglobulins Market Value Forecast, by Applications, 2020–2026
12.3. Asia Pacific Immunoglobulins Market Value Forecast, by Route of Administration, 2020–2026
12.4. Asia Pacific Immunoglobulins Market Value Forecast, by End-user, 2020–2026
12.5. Asia Pacific Immunoglobulins Market Value Forecast, by Country/Sub-region, 2020–2026
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Immunoglobulins Market Attractiveness Analysis
12.6.1. By Applications
12.6.2. By Route of Administration
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Immunoglobulins Market Analysis and Forecast
13.1.1. Key Findings
13.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2020–2026
13.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2020–2026
13.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2020–2026
13.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2020–2026
13.5.3. Rest of Latin America
13.6. Latin America Immunoglobulins Market Attractiveness Analysis
13.6.1. By Applications
13.6.2. By Route of Administration
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Immunoglobulins Market Analysis and Forecast
14.1.1. Key Findings
14.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2020–2026
14.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2020–2026
14.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2020–2026
14.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2020–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Latin America Immunoglobulins Market Attractiveness Analysis
14.6.1. By Applications
14.6.2. By Route of Administration
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Market Share Analysis by Company (2018)
15.3. Company Profiles
15.3.2. CSL Behring
15.3.3. Kedrion Biopharma Inc
15.3.4. Grifols, S.A.
15.3.6. China Biologic Products Holdings, Inc
15.3.7. Biotest AG
15.3.9. LFB SA
Fact.MR offers custom research services that help clients to get specific research solutions